We are Tetrafluoroethylene-pentafluoroethyl iodide telomer CAS:25398-32-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Synonyms：
Perfluoroethyl iodide-tetrafluoroethylene telomer
1-Iodoperfluoro-C6-12-alkanes
Ethane, pentafluoroiodo-, telomer with tetrafluoroethene (9CI)
Pentafluoroethyl iodide-tetrafluoroethylene telomer
Pentafluoroiodoethane-tetrafluoroethylene telomer
1-Iodoperfluoroalkanes,C6-C12
Ethane, pentafluoroiodo-, telomer with tetrafluoroethylene (8CI)
Ethene, tetrafluoro-, telomer with pentafluoroiodoethane (9CI)
Ethene, 1,1,2,2-tetrafluoro-, telomer with 1,1,1,2,2-pentafluoro-2-iodoethane
Ethylene, tetrafluoro-, telomer with pentafluoroiodoethane (8CI)
Molecular Formula: C70F145I5
Molecular weight： 4230.04000
Density: 1.8
Boiling point: 60°C to 110°C (US/CA), 20°C to 135°C (EU)
Melting point: not available
Vapor pressure: 1270mmHg at 25°C
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.
Market News: For skin rash, the difference in response rates for anifrolumab versus placebo at week 52 were 13.5% SLE Disease Activity Index (SLEDAI), 15.5% British Isles Lupus Assessment Group index (BILAG) and 15.6% modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). For arthritis, differences in response rates were 8.2% SLEDAI, 11.8% BILAG and 12.6% joint response.5-bromo-2-nitrothiophene-3-carbaldehyde manufacturer.The analysis examined disease manifestations in the two most commonly impacted organ domains in SLE. Anifrolumab is a potential first-in-class type I interferon inhibitor. 5,6-Dichloro-2-pyrazinamine supplier A panel of Israeli vaccination experts advising the health ministry overwhelmingly approved the booster campaign late on Wednesday, Bennett said. People over 60 who received their second dose of the Pfizer vaccine at least five months ago will be eligible. Rhodium dioxide producer
